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ABSTRACT: Triphenylphosphine oxide forms halogen-bonded (XB) complexes with pentafluoroiodobenzene and a 1,4-diaryl-5-
iodotriazole. The stability of these complexes is assessed computationally and by 31P NMR spec-
troscopy in d8-toluene solution, where both complexes are weakly associated. This knowledge is 
applied to the design and synthesis of two self-complementary phosphine oxide-iodotriazole hybrids 
that incorporate a phosphine oxide XB acceptor and a 1,4-diphenyl-5-iodotriazole XB donor within 
the same molecule. The self-complementary design of these modules facilitates their assembly in 
both d8-toluene and, surprisingly, d2-DCM into dimers, with significant stabilities, through the for-
mation of halogen-bonded diads. The stability of these assemblies is a result of significant levels of 
cooperative binding that is present in both solvents. The connection of two of these hybrid units 
together, using a flexible spacer, facilitates the aggregation of these modules in d2-DCM solution, 
through halogen bonding, forming oligomeric assemblies. 
INTRODUCTION 
Over the last two decades, the halogen bond (XB) – the 
noncovalent interaction1 between an electron-deficient halogen 
atom and a Lewis base – has evolved from a weak intermolec-
ular interaction of largely academic curiosity usually discussed 
in the context of solid state structures to a fully-fledged mem-
ber of the supramolecular toolkit. Undoubtedly, this dramatic 
change is a result of the seminal work of the group of Metran-
golo and Resnati2 and others3 during the late 1990s and early 
2000s. Today, XB interactions are employed in many fields of 
the chemical sciences, e.g. crystal engineering,4 medicinal 
chemistry,5 materials chemistry,6 nanoscience.7 Fundamental 
studies8 have highlighted how single point XB complexes 
between well-studied classes of neutral donors and acceptors 
in the solid state are generally weak when transferred to solu-
tion. Therefore, the creation of functional XB-based supramo-
lecular assemblies that are stable in solution requires complex-
es between XB donors and acceptors with far higher intrinsic 
stabilities than those involved in classical, solid state studies. 
Several research groups have circumvented these limitations 
by implementing cationic XB donors within organic struc-
tures, thus realizing a variety of molecular scaffolds able to 
perform as sensors9 and supramolecular catalysts10 through 
charge-assisted halogen bonding. An alternative strategy to 
overcome the limited stability of single point neutral XB inter-
actions involves exploiting cooperativity.11 The design of tri-
meric,12 tetrameric,13 even polymeric14 XB donors, based on 
the iodoperfluorobenzene unit, able to interact with comple-
mentary multidentate XB acceptors has allowed the realization 
of multipoint XB complexes with stability constants compara-
ble to those shown by conventional noncovalent interactions in 
solution.  
The last 30 years has seen an explosion of non-covalent as-
semblies that are stabilized through the concatenation of hy-
drogen bond donors and acceptors into contiguous diads,15 
triads16 and tetrads,17 giving rise to a rich diversity of supramo-
lecular oligo- and polymeric assemblies that are stable in solu-
tion. However, this approach to the construction of non-
covalent assemblies stabilized by halogen bonds is still in its 
infancy. Our laboratory has developed self-complementary 
diads that exploit the XB donating properties of 1,4-diphenyl-
5-iodotriazoles and their interaction with both neutral nitro-
gen18 and charged oxygen19 XB acceptors to afford halogen-
bonded dimers with measurable stability in organic solvents. 
Systems that bear a formal charge present a particular design 
challenge when considering self-complementary structures, as 
these assemblies suffer inherently through their design from 
significant electrostatic repulsion. In this work, we describe an 
optimized self-complementary dimeric design that features an 
iodotriazole XB donor and a triphenylphosphine oxide as the 
XB acceptor. Phosphine oxides incorporate an acceptor atom 
that bears a formal charge within a functional group that is 
neutral overall. Therefore, this functional group represents an 
excellent compromise between weak, neutral XB acceptors, 
such as pyridine, and charged phenoxide XB acceptors, which 
introduce significant electrostatic repulsion when incorporated 
within homodimeric assemblies. Despite the fact that Rissanen 
and co-workers have highlighted20 the potential of N-oxides as 
XB acceptors in solution recently, there are few fundamental 
studies that focus on XBs formed between N-oxides21 or phos-
phine oxides22 and typical XB donors, especially in solution. 
Here, we report the computational and experimental assess-
ment of the interaction between triphenylphosphine oxide and 
neutral XB donors. This knowledge is applied to the design 
and synthesis of self-complementary phosphine oxide-
 iodotriazole hybrid –incorporating both a phosphine oxide XB 
acceptor and a 1,4-diphenyl-5-iodotriazoles XB donor within 
the same molecule. This module is capable of homodimeriza-
tion as a halogen bonded diad in both d8-toluene and d2-DCM 
and this assembly exhibits significant levels of cooperative 
binding in both solvents. The connection of two of these hy-
brid units together, using a flexible spacer, facilitates the ag-
gregation of these modules in solution, through halogen bond-
ing, forming oligomeric assemblies. 
RESULTS AND DISCUSSION 
The ability of phosphine oxides to accept halogen bonds has 
been well documented22a–d in the solid state. The highly polar-
ized nature of the phosphorus-oxygen bond renders the oxygen 
atom a strong Lewis base and, thus, a powerful XB acceptor 
able to promote the formation22a of cocrystals with a variety of 
XB donors that are otherwise hard to crystallize. In solution, 
on the other hand, only a handful of association constants have 
been reported for XB complexes formed between phosphine 
oxides, acting as the XB acceptor and XB donors, such as 
perfluorohalocarbons8b,23 (PFHCs) and phenyliodoacety-
lenes.8d  
In order to facilitate the design of more complex structures, 
we initially probed the structure and bonding in simple com-
plexes formed between triphenylphosphine oxide TPPO and 
perfluoroiodobenzene PFIB and model iodotriazole ITZ. We 
performed a series of calculations on the [PFIB•TPPO] and 
[ITZ•TPPO] complexes in toluene solution at the 
TPSSh/def2-TZVP level of theory. The geometries and stabili-
ties of the two complexes are shown in Figure 1a.  
 
Figure 1. (a) Geometric parameters and calculated enthalpies of complexation (numbers in bold type, in kJ at 298 K) for the 
complexes [PFIB•TPPO] and [ITZ•TPPO]. (b) Visualization of the non-covalent interactions present in the complexes 
[PFIB•TPPO] and [ITZ•TPPO]. Left: Intermolecular interaction isosurfaces generated by NCIPLOT24 for s = 0.5 and –0.05 < 
sign(λ2)ρ < 0.05 (colour scale: attractive (blue) → repulsive (red)). Right: Plots of sign(λ2)ρ vs. reduced gradient highlighting the 
favourable interaction corresponding to the halogen bond at sign(λ2)ρ ~ –0.035. Atom colouring: C atoms = gray, N atoms = blue, 
O atoms = red, I atoms = purple, P atoms = orange. H atoms omitted for clarity. (c) Visualization of the n → s* interactions present 
in the [PFIB•TPPO] complex. Equivalent interactions are also present in the [ITZ•TPPO], see Supporting Information. 
 
Both complexes have enthalpies of complexation that are 
significantly negative at 298 K. The O•••I distances in both 
complexes are similar – [PFIB•TPPO], d(O•••I) = 2.782 Å 
and [ITZ•TPPO], d(O•••I) = 2.776 Å – and are significantly 
less than the sum of the van der Waals radii for O and I (Σvdw 
= 3.50 Å). These distances are similar to those calculated19 at 
the same level of theory for neutral XB acceptors, such as the 
oxygen atom in 4-pyridone (d(O•••I) ~ 2.80 Å), and signifi-
cantly larger than those associated with anionic acceptors, 
such as a phenoxide oxygen atom (d(O•••I) ~ 2.50 Å). As ex-
pected, analysis of the reduced gradient24 of the electron densi-
ty (Figure 1b) reveals significant low density, low gradient 
regions associated with the both complexes that are signifi-
cantly attractive (sign(λ2)ρ ~ –0.03).  
We were intrigued by the geometry of these complexes in 
which the P–O bond in the XB acceptor subtends an angle of 
around 150° to the C–I bond in the XB donor. This geometry 
is readily understood in terms of the significant donation from 
non-bonding orbitals on the O atom of the phosphine oxide 
acceptor and the σ* orbital associated with the C–I bond. Nat-
ural bond analysis (NBO) analysis25 (Figure 1c) reveals that 
the observed geometry is, in part, a result of the interplay be-
tween n → σ* donation associated with two of the lone pairs is 
present on the phosphine oxide and these interactions result in 
a deviation of the P–O•••I angle observed in the complexes 
away from 180°. 
In order to provide an experimental baseline for our studies, 
we first measured the association between perfluoroiodoben-
zene PFIB (the XB donor) and triphenylphosphine oxide 
TPPO (the XB acceptor) in d8-toluene solution at 295 K. The 
strength of this interaction in solution can be measured readily 
using 31P NMR spectroscopy as the phosphorus chemical shift 
is particularly sensitive22d to the formation of a halogen bond. 
Accordingly, TPPO was titrated with increasing amounts of 
PFIB in d8-toluene at 295 K and a 121.3 MHz 31P NMR spec-
trum recorded at each titration step. Upon addition of PFIB, 
 the 31P resonance of TPPO was shifted significantly down-
field (Δδ(31P) > +1.40; [TPPO] = 10 mM; [PFIB] = 500 mM). 
These data were fitted26 to a 1:1 binding model for the com-
plex [PFIB•TPPO] affording (see Supporting Information for 
details) a stability constant for this complex of 2.7 ± 0.3 M–1 in 
d8-toluene at 295 K. Chemical shift changes that arise from 
non-specific interactions associated with the addition of high 
concentrations of PFIB were discounted by repeating the ex-
periment, adding hexafluorobenzene instead of PFIB. In this 
case, the observed chemical shift change was much smaller 
(−0.22 ppm) and in an upfield, rather than a downfield, direc-
tion (see Supporting Information for further details). 
 
 
 
 
Figure 2. Connecting a triphenylphosphine oxide XB acceptor to 
an iodotriazole XB donor results in compound 2 that is capable of 
associating to form a homodimer stabilized by two halogen bonds. 
The geometry of this dimer at the TPSSh/def2-TZVP level of 
theory reveals an almost centrosymmetric dimer with d(O•••I) = 
2.771 Å and d(O•••I) = 2.768 Å. Intermolecular interaction isosur-
faces generated by NCIPLOT24 for s = 0.5 and –0.05 < sign(λ2)ρ 
< 0.05 (colour scale: attractive (blue) → repulsive (red)) high-
lights the favourable interaction corresponding to the halogen 
bond at sign(λ2)ρ ~ –0.05 (pale blue isosurface). Atom colouring: 
C atoms = gray, N atoms = blue, O atoms = red, F atoms = green, 
P atoms = orange, I atoms = purple. H atoms are omitted for clari-
ty. 
When this titration was repeated, using 4-(3,5-di-tert-
butylphenyl)-5-iodo-1-(perfluorophenyl)-1H-1,2,3-triazole 1 
as the XB donor, a similar pattern of chemical shift changes 
was observed for the 31P resonance of TPPO (Δδ(31P) > +2.00; 
[TPPO] = 10 mM; [1] = 0 – 200 mM). In this instance, fitting 
of these data to a 1:1 binding model for the complex 
[1•TPPO] afforded (see Supporting Information for details) a 
stability constant of 6.0 ± 0.3 M–1 in d8-toluene at 295 K. In 
common with other XB interactions in solution, these associa-
tion constants are rather small and these results suggest that 
TPPO behaves in a very similar manner to other neutral XB 
acceptors when interacting with neutral XB donors.  
Chelate cooperativity has been used successfully in several 
contexts27 for creating stable, supramolecular assemblies in 
solution using hydrogen bonds. In terms of XB interactions, 
similar exploitation12,13,18,19 of cooperativity is in its infancy. 
With the aim of exploiting cooperative binding within a ho-
modimeric assembly, we designed compound 2, which bears 
both an XB donor (the iodotriazole) and an XB acceptor (the 
phosphine oxide). 
The calculated structure (TPSSh/def2TZVP) of the [2•2] 
homodimer (Figure 2) is approximately centrosymmetric and 
is characterized by two short I•••O–P XB contacts – d(O•••I) = 
2.771 Å and d(O•••I) = 2.768 Å and ∠(O•••I–C) = 179.8°. The 
calculated enthalpy for the formation of the homodimer in 
toluene at 298 K is −53.8 kJ. Examination of the reduced gra-
dient of the electron density in dimer [2•2] reveals two low 
density, low gradient regions between the O and I atoms asso-
ciated with the halogen bonds (pale blue, Figure 2) and some 
additional weakly attractive, van der Waals-like areas of inter-
actions along the spine of the dimer (green, Figure 2). Natural 
Bond Orbital (NBO) analysis25 of the [2•2] dimer reveals that 
the sum of the second order perturbation energies for the inter-
actions between the lone pairs located on the phosphine oxide 
and the σ* orbitals associated with the iodotriazole two C–I 
bonds are 36.4 kJ, suggesting that this interaction could play a 
relatively important role in stabilizing the homodimer. 
Iodotriazole 2 was synthesized readily, starting from (4-
ethynylphenyl)diphenylphosphine oxide 3, (Scheme 1). Io-
dination of alkyne 3 was achieved by treatment with N-iodo 
morpholinium iodide using a modification of the procedure 
described28 by Sharpless and Fokin. The copper-catalyzed 
cycloaddition between iodoalkyne 4 and pentafluorophenyl 
azide 5, in the presence of the tris((1-benzyl-1H-1,2,3-triazol-
4-yl)methyl)amine TBTA, afforded the target phosphine oxide 
2 in 31% overall yield starting from 3. 
Scheme 1.  
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 In order to assess the ability of 2 to homodimerize in solu-
tion, a 31P NMR dilution experiment in d8-toluene at 295 K 
was performed. Sadly, the poor solubility of iodotriazole 2 in 
this solvent – a saturated solution has a concentration of less 
than 2 mM – limited the range of dilution experiments that 
could be performed using 31P NMR spectroscopy. Despite the 
observations of small chemical shift changes in the 202.4 MHz 
31P NMR spectrum of 2 upon dilution of a 1.5 mM solution in 
d8-toluene at 295 K to 0.5 mM, the stability of homodimer 
[2•2] could not be determined from these data. We reasoned 
that, in order to fully exploit the homodimeric binding motif 
shown in Figure 2, a more soluble version of iodotriazole 2 
had to be designed. This redesign focused on the replacement 
of the fluorine atom in the para position of the pentafluoro-
phenyl ring in 2 with an n-octyl ester group. Iodotriazole 6 
could be synthesized using identical methodology to that de-
scribed previously (Scheme 2). Esterification of commercially 
available pentafluorobenzoyl chloride 7 with n-octanol in THF 
afforded ester 8. Subsequently, the SNAr reactivity29 of the 4-
position of a monosubstituted pentafluorophenyl ring was 
exploited to introduce the azide group into the aromatic ring 
by reacting 8 with sodium azide in an acetone-water mixture 
(1:1) affording the 1,4-disubstituted tetrafluorobenzene 9. The 
final cycloaddition step between azide 9 and iodoalkyne 4 in 
presence of the copper(I)-TBTA complex allowed the facile 
preparation of the target iodotriazole 6. 
Scheme 2.  
 
Single crystals of 6, suitable for analysis by X-ray diffrac-
tion, were grown by slow evaporation of a concentrated solu-
tion of 6 in acetonitrile. The solid-state structure of 6 reveals 
(Figure 3) an antiparallel orientation of the P–O bond in 6 
with respect to the C–I bond within the same molecule and 
this geometry results in the formation of halogen-bonded tapes 
rather than discrete homodimeric assemblies. An analogous 
crystal packing motif is also observed for iodotriazole 2 (see 
Supporting Information). The halogen bonds present in the 
solid state structure of 6 are short (d(O•••I) = 2.720 Å, 0.8 Å 
shorter than ΣvdW) and linear (∠(O•••I–C) = 171.5°) and the 
geometry is in excellent agreement with our calculations. In 
addition, there are also short contacts (0.15 Å shorter than 
ΣvdW) between the carbonyl oxygen atom of an ester group in 
one molecule of 6 and the fluorinated aromatic ring of an ad-
jacent molecule in the crystal. 
 
Figure 3. Stick representation of the solid-state structure of 6 de-
termined from single crystal X-ray diffraction data. Atom colour-
ing: C atoms = gray, N atoms = blue, O atoms = red, F atoms = 
green, P atoms = orange, I atoms = purple. 
The solubility of iodotriazole 6 in toluene was found to be 
significantly better than that of 2 – a saturated solution of 6 in 
this solvent has a concentration of more than 20 mM. This 
improved solubility allowed us to carry out appropriate dilu-
tion experiments in d8-toluene in order to evaluate the stability 
of the [6•6] homodimer. Significant upfield chemical shift 
changes for the single phosphorus resonance were observed in 
the 202.4 MHz 31P NMR spectra, recorded on a solution of 6 
at increasing dilutions in d8-toluene from 20 mM down to 
1 mM. These chemical shift changes were fitted to a dimeriza-
tion binding model26 affording an association constant for the 
formation of the homodimeric species [6•6] (Kdimer) of 174 ± 
36 M–1 at 295 K in d8-toluene. 
In order to establish the magnitude of cooperativity 
achieved by connecting the phosphine oxide XB acceptor to 
the iodotriazole XB donor within the [6•6] homodimer, we 
quantified the effective molarity11 (EM) for binding within the 
[6•6] homodimer and the associated connection free energy30 
(∆GS). The measurement of the thermodynamic effective mo-
larity requires determination of an appropriate reference asso-
ciation constant. In order to obtain this comparison data, iodo-
triazole 10 (Figure 4a) was prepared by copper-mediated cy-
cloaddition of azide 9 with (iodoethynyl)benzene. Measure-
ment of the single point association constant Kref for the 
[10•TPPO] complex at 295 K in d8-toluene by 31P NMR spec-
troscopy afforded a value of 5.6 ± 0.5 M–1 (Figures 4b). The 
effective molarity for the formation of homodimer [6•6] can 
then be evaluated30 from the ratio of Kdimer for the [6•6] ho-
modimer to (Kref)2 – this calculation afforded a value of the 
EM of 5.7 M and corresponds to a connection free energy, 
∆GS, of 4.3 kJ mol–1. These values are similar to the largest 
values reported27,31 for hydrogen-bonded dimers where EM 
and ∆GS values are available. 
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Figure 4. (a) (i) Dimerization of the phosphine oxide-appended 
iodotriazole 6. (ii) Partial 202.4 MHz 31P NMR spectra showing 
the progressive upfield shift observed upon dilution of a 20 mM 
solution of iodotriazole 6 down to 2.5 mM in d8-toluene at 295 K. 
(b) (i) Formation of the single point XB complex between model 
iodotriazole 10 and XB acceptor TPPO. (ii) Partial 202.4 MHz 
31P NMR spectra showing the progressive downfield shift ob-
served upon titrating a 10 mM solution of TPPO with increasing 
amounts of iodotriazole 10 (0 to 150 mM) in d8-toluene at 295 K. 
Given the intrinsic stability of the [6•6] homodimer and its 
ease of synthesis, we considered that our dimeric design could 
be exploited as the noncovalent binding motif of a solution-
stable supramolecular polymer supported by halogen-bonded 
dimers. Many laboratories have demonstrated32 supramolecu-
lar polymerization driven by a variety of noncovalent interac-
tions. All of these studies use the covalent connection of two 
self-complementary units using an appropriate spacer in order 
to achieve polymerization. However, to the best of our 
knowledge, this approach has never been applied to a solution-
stable supramolecular polymer based on XBs. In order to ex-
ploit the [6•6] homodimer in this context, we required that two 
units of 6 be connected covalently. The most convenient way 
of realizing this objective was linking the two carboxy termini 
of 6 by a flexible pentamethylene spacer, affording the 
bis(phosphine oxide) 11. Compound 11 was synthesized in 
32% overall yield (Scheme 3) using similar methodology to 
that employed previously. 
 
Scheme 3.  
 
 
In common with iodotriazole 2, compound 11 displayed 
very poor solubility in d8-toluene – a saturated solution of 11 
in this solvent has a concentration below 2 mM. Fortuitously, 
however, 11 is freely soluble in d2-DCM – solutions with con-
centrations of up to 500 mM can be prepared readily at room 
temperature. Therefore, we performed an experiment in which 
a solution of 11 in d2-DCM at 298 K was diluted from a start-
ing concentration of 500 mM to 1 mM in eight steps and the 
chemical shift of the single 31P resonance arising from 11 was 
determined by 202.4 MHz 31P NMR spectroscopy at each step. 
There is a significant upfield shift of this resonance from 28.5 
ppm at 500 mM to 27.0 ppm at 1 mM. In addition, the single 
31P resonance arising from 11 is relatively broad at high con-
centrations, becoming progressively sharper upon dilution. 
The upfield shift, together with the concomitant sharpening of 
the 31P resonance observed upon dilution, suggests the for-
mation of molecular aggregates of 11, stabilized by halogen 
bonds, that are larger than the dimer [11•11].  
In order to evaluate this hypothesis, it is necessary to under-
stand the behavior of the core intermolecular interaction driv-
ing the oligomerization of 11, namely the homodimerization 
of the phosphine oxide-iodotriazole hybrid modules, in d2-
DCM solution. Since 11 is a covalently linked dimer of 6, this 
process can be modelled readily by studying the assembly of 
homodimer [6•6] in d2-DCM. Halogen bonds formed between 
neutral organic XB donors and acceptors usually have limited 
stabilities8b,23 in halogenated solvents such as d2-DCM. There-
fore, we firstly assessed the formation of the single point XB 
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 complex [10•TPPO] in d2-DCM. The addition of increasing 
amounts of iodotriazole 10 (from 1 to 10 equivalents) to a 5 
mM solution of TPPO in d2-DCM resulted in minimal chang-
es in the chemical shift of the 31P resonance of the XB accep-
tor (TPPO) – the maximum chemical shift change observed 
was only 0.13 ppm. This result indicates that the [10•TPPO] 
complex is only very weakly bound in d2-DCM and it was 
impossible to fit this chemical shift data to a 1:1 binding mod-
el for [10•TPPO]. By contrast, the 31P chemical shift changes 
observed upon diluting a 200 mM solution of iodotriazole 6 
down to 1 mM in d2-DCM could be fitted readily to a dimeri-
zation model for the formation of [6•6], affording an associa-
tion constant of 3.4 ± 0.3 M–1 for this complex. This result is 
somewhat surprising and confirms the presence of the cooper-
ative effect that is the result of connecting the two XB partners 
within one molecular module has on the overall stability of the 
halogen bonded complex. Although the stability of the single 
point [10•TPPO] complex could not be measured directly in 
d2-DCM, we can estimate its stability using the association 
constant of homodimer [6•6] in d2-DCM. Assuming that the 
effective molarity measured for the homodimerization of 6 in 
d8-toluene is identical in d2-DCM, the association constant of 
the singly halogen bonded complex [10•TPPO] in d2-DCM is 
0.8 M–1, corresponding to half saturation concentration Kd of 
1.25 M. This concentration is well beyond that which is acces-
sible experimentally for these compounds. The determination 
of the association constant for the dimer [6•6] at lower tem-
peratures revealed that, as expected, this complex becomes 
more stable as the temperature is reduced – the association 
constant for [6•6] increases from 3.2 ± 0.6 M–1 at 298 K to 
8.8 ± 0.7 M–1 at 238 K. These data allowed us to extract ther-
modynamic parameters for [6•6] dimer in d2-DCM, affording 
values for ΔH (– 9.3 kJ mol–1) and ΔS (–2.6 J mol–1 K–1) of 
binding. Therefore, the association of [6•6] is driven by a fa-
vorable enthalpic term, offset by a modestly unfavorable en-
tropic contribution. These observations match8d,13b those of 
other halogen-bonded systems where enthalpy and entropy 
data are available. With this information in hand, we were now 
able to construct a plausible model that describes the 31P NMR 
chemical shift changes that are observed when solutions of 11 
in d2-DCM are diluted.  
Figure 5. (a) Isodesmic or equal K model of supramolecular 
polymerization. The expected 31P chemical shift, δ(31P), can be 
computed from the unbound chemical shift, δfree, the limiting 
chemical shift difference between bound and unbound states, 
Δδlimit,  the association constant, K1, and [11]total. Best fits (dotted 
lines) of the isodesmic model to 31P chemical shift data (filled 
circles) for solutions of 11 in d2-DCM at 278 K (b, left) and 295 K 
(c, left). This model can also be used to predict the fraction of 
species in solution at 278 K (b, right) and 295 K (c, right). Red 
lines represent monomeric 11, blue lines represent the [11]2 dimer 
and green lines represent oligomers of 11 containing three or 
more monomer units. (d) Scanning electron micrograph of a sam-
ple of 6 deposited from a 20 mM solution in d2-DCM at 298 K. 
(e) Scanning electron micrograph of a sample of 11 deposited 
from a 20 mM solution in d2-DCM at 298 K. 
Over the past 20 years, several models33 of non-covalent 
polymerization have been developed. The simplest of these 
models is the isodesmic or equal K model34 in which monomer 
units are added sequentially and reversibly to the chain ends of 
growing oligomers (Figure 5a) according to an equilibrium 
model in which each chain extension step has the same equi-
librium constant, K1. 
 We could obtain excellent fits (Figures 5b and 5c, left) for 
the 31P chemical shift data obtained for solutions of 11 in d2-
DCM at both 278 K and 295 K to this isodesmic oligomeriza-
tion model. At 295 K, the best fit values for the limiting chem-
ical shift difference between the free and bound states 
(+3.3 ppm) and the association constant, K1, (3.9 M–1) both lie 
within the error limits of the values obtained for the model 
[6•6] dimer at a similar temperature in d2-DCM. However, at 
278 K, although the best fit value for the limiting chemical 
shift difference between the free and bound states (+2.9 ppm) 
is essentially identical to that determined for the [6•6] dimer at 
278 K, the best fit value of the association constant, K1, is 9.4 
M–1 is somewhat larger than that determined for the [6•6] di-
mer at 278 K (4.0 M–1). However, the two values are still with-
in the 3σ error limits of each other and the difference may 
reflect the assumptions made in deriving the isodesmic model 
rather than any fundamental changes in the assembly process-
es within the two samples. Diffusion ordered NMR spectros-
copy also reveals significant differences between the aggrega-
tion behavior of the model compound 6 and 11 in d2-DCM 
solution at 298 K. Above a concentration of 50 mM, the diffu-
sion coefficient, D, measured for compound 11 is more than 
three times less that that measured for compound 6 under the 
same conditions (see Supporting Information for details), sug-
gesting that at higher concentrations, 11 is aggregated signifi-
cantly. These differences in behavior can be visualized 
through examination of dried samples of 6 (Figure 5d) and 11 
(Figure 5e) using scanning electron microscopy (SEM). These 
images provide further evidence for the oligomerization of 11 
in d2-DCM solution. Samples of 6 were deposited on the SEM 
target from a 20 mM solution in d2-DCM at room temperature 
and allowed to dry rapidly in air. This treatment results in the 
deposition of µm-sized microcrystallites of 6 on the surface of 
the target (Figure 5d). By contrast, when the same experiment 
was repeated using a 20 mM solution of 11 in d2-DCM at 
room temperature, a smooth film (Figure 5e) was deposited 
on the surface. This film is extremely smooth over areas larger 
than 1500 µm2. 
CONCLUSION 
In the expanding lexicon of intermolecular interactions, hal-
ogen bonds constitute a particular challenge for chemists who 
wish to exploit these interactions for the realization of stable 
and functional self-assembled structures in solution. In con-
trast to hydrogen bonds, there are few, if any, empirical rule 
sets that exist to guide the design of stable arrays of halogen 
bonds in solution. The results presented here highlight the 
potential of concatenating halogen bonds into a stable diad, 
which follow design rules applied to the more common hydro-
gen bonds. This diad exhibits considerable positive coopera-
tivity in its assembly and facilitates the assembly of a halogen-
bonded dimer, constructed from neutral XB donors and accep-
tors, that is stable in both d8-toluene and d2-DCM solution. 
The challenge moving forward is to extend these principals to 
XB triads and tetrads that are capable of exploiting coopera-
tive binding to create assemblies in solution that rival those 
created using hydrogen bonds.  
 
EXPERIMENTAL SECTION 
General Experimental Methods. All starting material were pur-
chased from commercially available sources and used as obtained 
unless otherwise specified. 4-(3,5-Di-tert-butylphenyl)-5-iodo-1-
(perfluorophenyl)-1H-1,2,3-triazole18 (1), (4-ethynyl)diphenyl phos-
phine oxide35 (3), N-iodo morpholinium iodide,28 (tris((1-benzyl-1H-
1,2,3-triazole-4-yl)methyl) amine36 (TBTA), pentafluorophenyl az-
ide37 (5) and (iodoethynyl)benzene28 (12) were prepared according to 
literature procedures.  
1H, 13C, 19F and 31P NMR spectroscopic data were acquired at a 
constant temperature of 25 ºC unless stated otherwise. 1H and 13C 
chemical shift are reported in parts per million (ppm) from high to 
low field and referenced to the literature values for chemical shift of 
the residual non-deuterated solvent, with respect to tetramethylsilane. 
19F NMR chemical shift are referenced to CFCl3 (0.00 ppm). 31P 
chemical shift are referenced to PPh3 (–6.00 ppm).  
Electrospray ionization (ESI) spectra were recorded in positive ion 
mode, m/z values are reported in Daltons.  
SEM samples were air-dried and coated with gold (Quorum Q150R 
ES) at 10 mA for 30 seconds, SEM images were taken with a field 
emission gun electron source running at 5 kV.  
Association constants were determined from 31P NMR spectro-
scopic data using WinEQNMR.26 
 
Computational Details. 
All calculations were performed using Gaussian0938 suite of pro-
grams – revision D.01 was used in all calculations. Calculation 
were performed using TPSSh39 functional and the def2-TZVP 
basis set40 of Weigend and Ahlrichs. This basis set was introduced 
into the calculation using the GenECP keyword and an appropri-
ately-formatted input block for the basis set generated from data 
obtained from the Basis Set Exchange41 
(https://bse.pnl.gov/bse/portal). An effective core potential on 
iodine,42 which replaces 28 valence electrons on each iodine atom 
was used in all calculations. The calculations were all-electron for 
all other elements. All geometries were optimized fully in internal 
(keyword: opt) or cartesian (keyword: opt=cartesian) coordi-
nates using the default optimisation protocols within Gaussian09. 
Stationary points were characterised by means of a vibrational 
analysis (keyword: freq) and zero-point energy corrections and 
other thermodynamic parameters, used in the calculation of inter-
actions energies, were derived43 from this analysis. Population 
analyses using the Natural Bond Orbital (NBO) method were 
performed using the NBO6 program25 in a two-stage procedure. 
The input for NBO6 was generated using Gaussian09 (keyword: 
population=nboread) and the .47 file generated by this calcu-
lation was then edited and processed using the gennbo script 
provided with the NBO6 distribution. All analyses used the 8-byte 
integer version of NBO6 (6.0.13, dated July 2016) compiled from 
source using gfortran (Version 4.4.7). The basis set superposition 
error was calculated using the counterpoise method44 as imple-
mented within Gaussian09 (keyword: counterpoise = 2). 
Halogen bonds were visualized using the NCIPLOT24 program. 
SCF densities written as an extended wavefunction file from 
Gaussian09 and NCIPLOT used to generate cube files from which 
isosurfaces could be visualised using VMD45 with s = 0.5 and an 
appropriate colour map (blue (attractive) to red (repulsive)) 
mapped on to  –0.05 < ρ < 0.05. 
 
Synthetic Procedures. (4-(Iodoethynyl)phenyl)diphenylphosphine 
oxide (4). N-Iodomorpholinium iodide (4.97 g, 14.6 mmol) was added 
to a solution of (4-ethynylphenyl)diphenylphosphine oxide 3 (3.3 g, 
10.9 mmol) in 24.0 mL of THF. The mixture thus obtained was stirred 
at room temperature for 12 hours. After this time, the reaction was 
concentrated under reduced pressure to remove the bulk of the THF 
and redissolved in ethyl acetate and, as such, transferred into a sepa-
rating funnel. The organic phase was washed three times with 1 M 
sodium thiosulfate aqueous solution then brine, dried over MgSO4, 
filtered and concentrated in vacuo. Crystallization of the crude mate-
rial in hot acetonitrile afforded 3.3 g of iodoalkyne 4 as a yellow solid 
(7.7 mmol, 53%). Crystals suitable for single crystal X-ray diffraction 
were obtained upon cooling of a saturated acetonitrile solution.  
1H NMR (500.1 MHz, CDCl3): δ 7.65 – 7.58 (m, 6H), 7.56 – 7.52 (m, 
 2H), 7.50 – 7.43 (m, 6H). 31P NMR (202.4 MHz, CDCl3): δ 28.7. 13C 
NMR (125.7 MHz, CDCl3): δ 132.9 (d, J = 103.4 Hz, 1C), 132.3 (d, 
J = 12.9 Hz, 1C), 132.2 (d, J = 3.0 Hz, 1C), 132.1 (d, J = 9.9 Hz, 1C), 
132.07 (d, J = 104.3 Hz, 1C), 131.9 (d, J = 10 Hz, 1C), 128.7 (d, J = 10 
Hz, 1C), 127.1 (d, J = 2.9 Hz, 1C), 93.21 – 93.20 (m, 1C), 11.37 – 
11.32 (m, 1C). HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for 
C20H14IONaP, 450.9701; found 450.9719. M.p. >191.1 ºC dec.. 
(4-(5-iodo-1-(perfluorophenyl)-1H-1,2,3-triazol-4-
yl)phenyl)diphenyl phosphine oxide (2). Ligand TBTA (37 mg, 0.07 
mmol) was stirred in THF (3.0 mL) with copper iodide (13 mg, 0.07 
mmol) for 20 minutes. Iodoalkyne 4 (0.30 g, 0.70 mmol) and azide 5 
(0.15 g, 0.70 mmol) were then dissolved in THF (1.0 mL) and added 
in a single portion to the catalyst mixture. The reaction mixture was 
stirred at room temperature for 12 hours and, after this time, quenched 
by adding an aqueous ammonium hydroxide solution (10%, 0.7 mL) 
and concentrated under reduced pressure. The crude mixture was then 
redissolved in ethyl acetate, washed with water, brine and finally 
dried over MgSO4, filtered and concentrated in vacuo. Purification by 
column chromatography (SiO2, 4:1 DCM: ethyl acetate), followed by 
crystallization from hot DCM, afforded the product as a white powder 
(0.26 g, 0.41 mmol, 58%). Crystals suitable for single crystal X-ray 
diffraction were obtained upon cooling of a saturated acetonitrile 
solution. 1H NMR (500.1 MHz, CDCl3): δ 8.19 – 8.17 (m, 2H), 7.84 – 
7.80 (m, 2H), 7.72 – 7.68 (m, 4H), 7.59 – 7.56 (m, 2H), 7.51–7.48 (m, 
4H). 31P NMR (202.4 MHz, CDCl3): δ 28.9. 19F NMR (470.5 MHz, 
CDCl3): δ −142.19 – −142.23 (m, 2F), −146.88 – −146.97 (m, 1F), 
−158.86 – −158.99 (m, 2F). 13C NMR (125.7 MHz, CDCl3): δ 149.4, 
144.9 – 142.6 (m, 1C), 139.3 – 136.9 (m, 1C), 133.9 – 133.1 (m, 1C), 
132.8 – 131.8 (m, 5C), 128.7 (d, J = 12.3 Hz, 1C), 127.3 (d, J = 12.1 
Hz, 1C), 112.5 – 112.2 (m, 1C), 81.6 – 81.5 (m, 1C), 53.6. HRMS 
(ESI-TOF) m/z: [M+Na]+ calcd. for C26H14F5IN3NaOP, 659.9737; 
found 659.9732. M.p. >204.6 ºC dec.. 
Octyl 2,3,4,5,6-pentafluorobenzoate (8). Pentafluorobenzoyl chlo-
ride 7 (2.00 g, 8.68 mmol) was added to a solution of n-octanol (1.56 
g, 11.98 mmol) in 1.5 mL of THF and the mixture thus obtained was 
refluxed for 5 hours. After cooling to room temperature, the reaction 
mixture was treated with an aqueous saturate solution of NaHCO3, 
diluted with ether and, as such, transferred in a separating funnel. The 
organic layer was washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure. Purification of the product was 
achieved by column chromatography of the concentrated crude (SiO2, 
4:1 petroleum ether: ethyl acetate) to afford 2.80 g of ester 8 (8.63 
mmol, 99%) as a colourless oil. 1H NMR (500.1 MHz, CDCl3): δ 4.36 
(d, J = 6.6 Hz, 2H), 1.77 – 1.71 (m, 2H), 1.43 – 1.38 (m, 2H), 1.34 – 
1.26 (m, 8H), 0.85 (t, J = 6.7 Hz, 3H). 19F NMR (470.5 MHz, CDCl3): 
δ −138.83 – −138.90 (m, 2F), −149.67 – −149.78 (m, 1F), −161.05 – 
−161.16 (m, 2F). 13C NMR (125.7 MHz, CDCl3): δ 159.2, 146.6 – 
144.3 (m, 1C), 144.2 – 142.0 (m, 1C), 138.9 – 136.7 (m, 1C), 108.7 
(td, J = 16.2 Hz and J = 4.0 Hz), 67.1, 31.9, 29.30, 29.26, 28.6, 25.9, 
22.8, 14.1. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for C15H17F5NaO2, 
347.1046; found 347.1022. 
Octyl 4-azido-2,3,5,6-tetrafluorobenzoate (9). Ester 8 (2.00 g, 6.17 
mmol) and sodium azide (0.84 g, 12.9 mmol) were dissolved in 14.0 
mL of a 1:1 acetone:water solution and the mixture thus obtained was 
heated to 80 ºC for 24 hours. After this time, the reaction was 
quenched with water and diluted with diethylether and, as such, trans-
ferred in a separating funnel. The organic layer was quenched with 
brine, dried over MgSO4, filtered and concentrated in vacuo. Purifica-
tion of the product was obtained by column chromatography (SiO2, 
8:1 to 7:3 petroleum ether: DCM) to afford 0.77 mg of 9 as a yellow 
oil (2.22 mmol, 36%). 1H NMR (500.1 MHz, CDCl3): δ 4.36 (d, J = 
6.6 Hz, 2H), 1.77 – 1.71 (m, 2H), 1.44 – 1.38 (m, 2H), 1.34 – 1.27 (m, 
8H), 0.88 (t, J = 7.0 Hz, 3H). 19F NMR (470.5 MHz, CDCl3): δ 
−138.87 – −138.97 (m, 2F), −150.99 – −151.09 (m, 2F). 13C NMR 
(125.7 MHz, CDCl3): δ 159.6 – 159.5 (m, 1C), 146.5 – 144.2 (m, 1C), 
141.7 – 139.5 (m, 1C), 123.3 – 123.1 (m, 1C), 108.2 (t, J = 15.8 Hz, 
1C), 67.0, 31.9, 29.3, 29.2, 28.6, 25.9, 22.8, 14.2. HRMS (ESI-TOF) 
m/z: [M+Na]+ calcd. for C15H17F4N3NaO2, 370.1155; found 370.1135. 
Octyl 4-(4-(4-(diphenylphosphoryl)phenyl)-5-iodo-1H-1,2,3-
triazol-1-yl)-2,3,5,6-tetrafluorobenzoate (6). Ligand TBTA (64 mg, 
0.12 mmol) was stirred in dry THF (5.0 mL) with copper iodide (23 
mg, 0.12 mmol) for 20 minutes. Iodoalkyne 4 (0.52 g, 1.21 mmol) 
and azide 9 (0.42 g, 1.21 mmol) were dissolved in THF (1.0 mL) and 
added in a single portion to the catalyst mixture. After stirring at room 
temperature for 12 hours, the reaction mixture was quenched with an 
aqueous ammonium hydroxide solution (10%, 1.2 mL) and concen-
trated under reduced pressure. The crude mixture was then redis-
solved in ethyl acetate, washed with water and brine and successively 
dried over MgSO4 filtered and concentrated in vacuo. Purification was 
achieved by crystallization from hot acetonitrile, affording iodotria-
zole 6 as a white powder (0.60 g, 0.77 mmol, 64%). Crystals suitable 
for single crystal X-ray diffraction were obtained upon cooling of a 
saturated acetonitrile. 1H NMR (500.1 MHz, CDCl3): δ 8.20 – 8.17 (m, 
2H), 7.84 – 7.80 (m, 2H), 7.72 – 7.68 (m, 2H), 7.59 – 7.56 (m, 2H), 
7.51 – 7.48 (m, 4H), 4.46 (t, J = 6.6 Hz, 2H), 1.82 – 1.77 (m, 2H), 1.47 
– 1.42 (m, 2H), 1.37 – 1.26 (m, 8H), 0.89 (s, 3H). 19F NMR (470.5 
MHz, CDCl3): δ −141.47 – −141.59 (m, 2F), −136.88 – −137.01 (m, 
2F). 31P NMR (202.4 MHz, 20 mM, CDCl3): δ 28.91.  
13C NMR (125.7 MHz, CDCl3): δ 158.6, 149.4, 145.7 – 143.4 (m, 1C), 
144.0 – 141.8 (m, 1C), 133.4 (d, J = 103.4 Hz, 1C), 132.6 – 131.7 (m, 
5C), 128.6 (d, J = 12.0 Hz, 1C), 127.2 (d, J = 12.5 Hz, 1C), 118.4 – 
118.1 (m, 1C), 116.3 (t, J = 16.8 Hz, 1C), 80.8, 67.7, 31.8, 29.14, 
29.10, 28.4, 25.7, 22.6, 14.1. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. 
for C35H31F4N3NaIPO3, 798.0976; found 798.0959. M.p: >185.0 ºC 
dec.. 
Octyl 2,3,5,6-tetrafluoro-4-(5-iodo-4-phenyl-1H-1,2,3-triazol-1-
yl)benzoate (10). Ligand TBTA (46 mg, 0.09 mmol) was stirred in 
THF (3.5 mL) with copper iodide (16 mg, 0.09 mmol) for 20 minutes. 
Iodoalkyne 4 (0.19 g, 0.86 mmol) and azide 9 (0.30 g, 0.86 mmol) 
were then dissolved in THF (0.5 mL) and added in a single portion to 
the catalyst mixture. After stirring at room temperature for 12 hours, 
the reaction mixture was quenched with an aqueous ammonium hy-
droxide solution (10%, 0.8 mL) and concentrated under reduced pres-
sure. The crude mixture was then redissolved in ethyl acetate washed 
with water and brine and successively dried over MgSO4 filtered and 
concentrated in vacuo. Purification was achieved by crystallization 
from hot acetonitrile, affording iodotriazole 10 as a white powder 
(0.60 g, 0.77 mmol, 64%). 1H NMR (500.1 MHz, CDCl3): δ 8.05 – 
8.03 (m, 2H), 7.54 – 7.45 (m, 3H), 4.46 (t, J = 6.5 Hz, 2H), 1.83 – 1.77 
(m, 2H), 1.48 – 1.42 (m, 2H), 1.37 – 1.22 (m, 8H), 0.89 (t, J = 6.4 Hz, 
3H). 19F NMR (470.5 MHz, CDCl3): δ −137.11 – −137.18 (m, 2F), 
−141.51 – −141.58 (m, 2F). 13C NMR (125.7 MHz, CDCl3): δ 158.6, 
150.6, 145.7 – 143.4 (m, 1C), 144.1 – 141.9 (m, 1C), 129.3, 129.0, 
128.8, 127.5, 118.6 – 118.3 (m, 1C), 116.1 (t, J = 16.8 Hz, 1C), 79.4, 
67.6, 31.8, 29.14, 29.10, 28.4, 25.7, 22.6, 14.1. HRMS (ESI-TOF) 
m/z: [M+H]+ calcd. for C23H23F4IN3O2, 576.0766; found 576.0752. 
M.p. 109.3 – 111.3 ºC. 
Pentane-1,5-diyl bis(2,3,4,5,6-pentafluorobenzoate)46 (12). Pen-
tafluorobenzoyl chloride 7 (8.8 g, 38.2 mmol) was added to a solution 
of 1,5-pentane diol (2.0 g, 19.2 mmol) in 6.4 mL of THF and the 
mixture thus obtained was refluxed for 12 hours. After cooling the 
reaction mixture to room temperature, a saturate solution of NaHCO3 
was added to neutralize the acid, the mixture was diluted with ethyl 
ether and, as such, transferred in a separating funnel. The organic 
layer was then washed with brine, dried over MgSO4, filtered and 
concentrated under reduced pressure to obtain 4.8 g of bis-ester 12 
(9.8 mmol, 51%) as a colorless oil. 1H NMR (500.1 MHz, CDCl3): δ 
4.40 (t, J = 7.1 Hz, 2H), 1.85 – 1.80 (m, 2H), 1.62 – 1.55 (m, 1H). 19F 
NMR (376.4 MHz, CDCl3): δ −138.36 – −142.47 (m, 2F), −148.55 – 
−148.67 (m, 1F), −160.35 – −160.50 (m, 2F). 13C NMR (125.7 MHz, 
CDCl3): δ 159.0, 146.5 – 142.0 (m, 2C), 138.8 – 136.5, 108.2 (dt, J = 
15.9 Hz and J = 3.9 Hz, 1C), 66.4, 27.9, 22.2. 
Pentane-1,5-diyl bis(4-azido-2,3,5,6-tetrafluorobenzoate) (13). 
Bis-ester 12 (3.0 g, 6.1 mmol) and sodium azide (0.84 g, 13.0 mmol) 
were dissolved in 14 mL of a 1:1 acetone:water solution and the mix-
ture was heated to 80 ºC for 4 hours. After cooling to room tempera-
ture, the reaction was quenched with water, diluted with diethyl ether 
and, as such, transferred in a separating funnel. The organic layer was 
washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo. No further purification was found necessary: 3.3 g of bis-azide 
13 (6.1 mmol, 100%) were obtained as a pale yellow solid. 1H NMR 
(500.1 MHz, CDCl3): δ 4.39 (t, J = 6.3 Hz, 2H), 1.79 – 1.84 (m, 2H), 
 1.61 – 1.56 (m, 1H). 19F NMR (470.5 MHz, CDCl3): δ −138.82 – 
−138.89 (m, 2F), −150.97 – −151.05 (m, 2F). 13C NMR (125.7 MHz, 
CDCl3): δ 159.5, 146.5 – 144.3 (m, 1C), 141.6 – 139.5, 123.4 (tt, J = 
11.9 Hz and J = 3.0 Hz, 1C), 107.9 (t, J = 15.5 Hz, 1C), 66.4, 28.1, 
22.4. HRMS (ESI-TOF) m/z: [M+Na]+ calcd. for C19H10F8N6NaO4, 
561.0516; found 561.0528. 
5-((4-(4-(4-(diphenylphosphoryl)phenyl)-5-iodo-1H-1,2,3-triazol-
1-yl)-2,3,5,6-tetrafluoro benzoyl)oxy) pentyl 4-(4-(4-(diphenyl phos-
phoryl)phenyl)-5-iodo-1H-1,2,3-triazol-1-yl)-2,3,5,6-
tetrafluorobenzoate (11). Ligand TBTA (47.7 mg, 0.09 mmol) was 
stirred in dry THF (3.8 mL) with copper iodide (17.1 mg, 0.09 mmol) 
for 20 minutes. Iodoalkyne 4 (0.79 g, 1.80 mmol) and bis-azide 13 
(0.50 g, 0.93 mmol) were dissolved in THF (5.0 mL) and added in a 
single portion to the catalyst mixture. After stirring at room tempera-
ture overnight, the reaction mixture was quenched with an aqueous 
ammonium hydroxide solution (10%, 1.8 mL) and concentrated under 
reduced pressure. The crude mixture was then redissolved in 
ethylacetate and washed with water, brine and dried over MgSO4 
filtered and concentrated in vacuo. Purification was achieved by crys-
tallization from hot acetonitrile, affording product 11 as a white pow-
der (0.89 g, 0.64 mmol, 64%). 1H NMR (500.1 MHz, CDCl3): δ 8.19 – 
8.17 (m, 4H), 7.84 – 7.80 (m, 4H), 7.72 – 7.68 (m, 8H), 7.59 – 7.55 (m, 
4H), 7.51 – 7.47 (m, 8H), 4.51 (t, J = 6.6 Hz, 4H), 1.94 – 1.88 (m, 4H), 
1.69 – 1.65 (m, 2H). 19F NMR (470.5 MHz, CDCl3): δ −136.87 – 
−136.94 (m, 2F), −141.31 – −141.38 (m, 2F). 31P NMR (202.4 MHz, 
20 mM, CDCl3): δ 28.96. 13C NMR (125.7 MHz, CDCl3): δ 158.6, 
149.4, 145.9 – 143.6 (m, 1C), 144.2 – 141.9 (m, 1C), 133.5 (d, J = 
103.4 Hz, 1C), 132.7 (d, J = 10.8 Hz, 1C), 132.3 (d, J = 2.8 Hz, 1C), 
132.2 (d, J = 9.9 Hz, 1C), 131.8, 128.7 (d, J = 11.9 Hz, 1C), 127.3 (d, J 
= 12.0 Hz, 1C), 118.6 – 118.4 (m, 1C), 116.1 (t, J = 16.6 Hz, 1C), 80.9, 
67.2, 28.1, 22.4. HRMS (ESI-TOF) m/z: [M+H]+ calcd. for 
C59H39F8I2N6O6P2, 1395.0368; found 1395.0328. M.p. >197.2 ºC dec.. 
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